Meanwhile, targeting the PTMs of key signaling molecules involved in TCR activation, such as ZAP70 and LAT, could restore T cell activity, enhance tumor recognition, and improve the anti-tumor immune response (62). The gene discussed is ZAP70; the disease is neoplasm.